drugset / Trial / NCT00364390
A Study of Anginera In Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a first in man, Phase I safety study of Anginera in adults with Left Ventricular Dysfunction (LVD) and Reversible Myocardial Ischemia undergoing a CABG procedure.
Timeline
- Start
- 2006-04
- Primary completion
- 2008-11
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anginera | Unknown | — | Other |